Actinomycin D specifically inhibits the interaction between transcription factor Sp1 and its binding site

Acta Biochimica Polonica

Volumn 45, Issue 1, 1998, Pages 67-73

  Czyz, Małgorzata ^a   Gniazdowski, Marek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Actinomycin D; DNA protein interactions; Sp1; Transcription factors

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DACTINOMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCALATING AGENT; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; HUMAN; METABOLISM; PROTEIN BINDING; VASCULAR ENDOTHELIUM;

ANTIBIOTICS, ANTINEOPLASTIC; BINDING SITES; CELLS, CULTURED; DACTINOMYCIN; ENDOTHELIUM, VASCULAR; HUMANS; INTERCALATING AGENTS; NF-KAPPA B; PROTEIN BINDING; TRANSCRIPTION FACTORS;

EID: 0031615464     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hurst, H.C. (1996) Transcription factors as drug targets in cancer. Eur. J. Cancer 32A, 1857-1863.
2. Laughton, C.A., Jenkins, T.C., Fox, K.R. & Neidle, S. (1990) Interaction of berenil with the tyrT DNA sequence studied by footprinting and molecular modelling. Implications for the design of sequence-specific DNA recognition agents. Nucleic Acids Res. 18, 4479-4488.
3. Churchill, M.E.A., Hayes, J.J. & Tullius, T.D. (1990) Detection of drug binding to DNA by hydroxyl radical footprinting. Relationship of distamycin binding sites to DNA structure and positioned nucleosomes of 5S RNA genes of Xenopus. Biochemistry 29, 6043-6050.
4. Van Dyke, W.W. & Dervan, P.B. (1983) Chromomycin, mithramycin and olivomycin binding sites on heterogenous DNA. Footprinting with (methidium propyl-EDTA)iron (II). Biochemistry 22, 2373-2377.
5. 3-DNA interaction. Biochemistry 31, 9310-9318.
6. Broggini, M. & D'Incalci, M. (1994) Modulation of transcription factor-DNA interactions by anticancer drugs. Anti-Cancer Drug Design 9, 373-387.
7. Bianchi, N., Passadore, M., Rutigliano, C., Feriotto, G., Mischiati, C. & Gambari, R. (1996) Targeting of the Sp1 binding sites of HIV-1 long terminal repeat with chromomycin - Disruption of nuclear factor-DNA complexes and inhibition of in vitro transcription. Biochem. Pharmacol. 52, 1489-1498.
8. Muller, J.M., Ziegler-Heitbrock, H.W.L. & Baeuerle, P.A. (1993) Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187, 233-256.
9. v gene: Identification and characterization of the promoter region. Biochim. Biophys. Acta 1219, 228-232.
10. Jaffe, E.A., Nachlman, R.L., Becker, C.G. & Minick, C.R. (1973) Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 53, 2745-2756.
11. Dignam, J.D., Lebovitz, R.M. & Roeder, R.G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489.
12. Moll, T., Czyz, M., Holzmuller, H., Hofer-Warbinek, R., Wagner, E., Winkler, H., Bach, F.H. & Hofer, E. (1995) Regulation of the tissue factor promoter in endothelial cells. J. Biol. Chem. 270, 3849-3857.
13. Sambrook, J., Fritsch, E.F. & Maniatis, T. (1989) in Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
14. Mac Leod, M.C., Powell, K.L., Kuzmin, V.A., Kolbanovskiy, A. & Geacintov, N.B. (1996) Interference of benzo[a]pyrene diol epoxidedeoxyguanosine adducts in a GC box with binding of the transcription factor Sp1. Mol. Carcinogenesis 16, 44-52.
15. Gray, P.J. (1995) Sulphur mustards inhibit binding of transcription factor AP 2 in vitro. Nucleic Acids Res. 23, 4378-4382.
16. Welch, J.J., Rauscher, F.J. III & Beerman,T.A. (1994) Targeting DNA-binding drugs to sequence-specific transcription factor : DNA complexes. J. Biol. Chem. 269, 31051-31058.
17. Gale, E.F., Cundliffe, E., Reynolds, P.E., Richmond, M.H. & Waring, M.J. (1981) Inhibitors of nucleic acid synthesis; in The Molecular Basis of Antibiotic Action; pp. 258-401, J. Wiley, N.Y.
18. Piestrzeniewicz, M.K., Wilmanska, D., Studzian, K., Szemraj, J., Czyz, M., Denny, W.A. & Gniazdowski, M. (1997) Inhibition of RNA synthesis in vitro by acridines - Relation between structure and activity. Z. Naturforsch., in press.
19. Ree, A.H., Maelandsme, G.M. & Fodstad, O. (1996) Regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in MCF-7 cells: Comparison with regulatory mechanisms of pS2 expression. Clin. Exp. Metastasis 14, 381-388.
20. Jaros-Kamińska, B., Małagocka, E., Ciesielska, E. & Gniazdowski, M. (1981) Comparison of inhibitory effect of various drugs on yeast and bacterial RNA polymerases. Studia Biophys. 86, 211-218.
21. Atwell, G.J., Baguley, B.C., Wilmanska, D. & Denny, W.A. (1986) Potential antitumor agents. 45. Synthesis, DNA-binding interaction, and biological activity of triacridine derivatives. J. Med. Chem. 29, 69-74.